Daws D. Ryan 4
4 · enGene Holdings Inc. · Filed Dec 4, 2023
Insider Transaction Report
Form 4
Daws D. Ryan
Chief Financial Officer
Transactions
- Award
Stock Option (Right to Buy)
2023-11-30+232,000→ 232,000 totalExercise: $7.66Exp: 2033-11-30→ Common Shares (232,000 underlying)
Footnotes (1)
- [F1]This option vests at 25% on the first anniversary of the grant date, with the remaining portion to vest monthly over the remaining three years.